as 05-09-2025 9:51am EST
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Founded: | 1892 | Country: | United States |
Employees: | N/A | City: | CHICAGO |
Market Cap: | 28.1B | IPO Year: | N/A |
Target Price: | $88.80 | AVG Volume (30 days): | 6.1M |
Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 4.76 | EPS Growth: | 38.77 |
52 Week Low/High: | $57.65 - $94.80 | Next Earning Date: | 04-30-2025 |
Revenue: | $19,799,000,000 | Revenue Growth: | 1.56% |
Revenue Growth (this year): | 3.77% | Revenue Growth (next year): | 4.61% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Newcomb George A. | GEHC | Chief Accounting Officer | Feb 18 '25 | Sell | $92.54 | 2,000 | $185,080.00 | 7,462 |
GEHC Breaking Stock News: Dive into GEHC Ticker-Specific Updates for Smart Investing
Investor's Business Daily
18 hours ago
Argus Research
a day ago
Argus Research
a day ago
Simply Wall St.
3 days ago
Business Wire
7 days ago
Simply Wall St.
7 days ago
Morningstar Research
8 days ago
Yahoo Finance Video
9 days ago
The information presented on this page, "GEHC GE HealthCare Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.